EA201201666A1 - Промежуточные соединения агомелатина и способ их получения - Google Patents

Промежуточные соединения агомелатина и способ их получения

Info

Publication number
EA201201666A1
EA201201666A1 EA201201666A EA201201666A EA201201666A1 EA 201201666 A1 EA201201666 A1 EA 201201666A1 EA 201201666 A EA201201666 A EA 201201666A EA 201201666 A EA201201666 A EA 201201666A EA 201201666 A1 EA201201666 A1 EA 201201666A1
Authority
EA
Eurasian Patent Office
Prior art keywords
agomelatine
preparation
intermediate compounds
present
new intermediates
Prior art date
Application number
EA201201666A
Other languages
English (en)
Other versions
EA020271B1 (ru
Inventor
Пэн Чжан
Ю Хуан
Чжедун Юань
Ханьбинь Шань
Сюй Юй
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45097542&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201201666(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA201201666A1 publication Critical patent/EA201201666A1/ru
Publication of EA020271B1 publication Critical patent/EA020271B1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/06Preparation of carboxylic acid amides from nitriles by transformation of cyano groups into carboxamide groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/22Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Abstract

Настоящее изобретение относится к промежуточным соединениям для получения агомелатина, так же, как и к способам их получения. Промежуточное соединение настоящего изобретения для получения агомелатина представляет собой соединение А в соответствии с следующей формулой. Также обеспечены два новых промежуточных соединения. Когда применяются эти новые промежуточные соединения для получения агомелатина, способ является простым для управления, хорошо контролируемым, и дает продукт с высокой чистотой, без сложных операций, таких как ректификация и разделение хроматографией на колонке, и является подходящим для промышленного производства. При этом, способы получения самих двух новых промежуточных соединений являются простыми и с высоким выходом, только когда применяют наиболее широко используемый 7-метокситетралон в качестве исходного стартового материала и проводят одну стадию реакции для получения промежуточных соединений с последующей еще одной стадией преобразования промежуточного соединения в желаемый продукт агомелатин. Упомянутые процессы реакции очень упрощены, с улучшенным выходом реакции, а также преодолевают трудности в очистке предыдущего способа при сравнении с предыдущей методикой получения агомелатина. Обычно выход настоящего изобретения составляет свыше 70%.
EA201201666A 2010-06-08 2011-06-08 Промежуточные соединения агомелатина и способ их получения EA020271B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2010101973700A CN102276492B (zh) 2010-06-08 2010-06-08 阿戈美拉汀中间体及其制备方法
PCT/CN2011/075438 WO2011153939A1 (en) 2010-06-08 2011-06-08 Agomelatine intermediates and preparation method thereof

Publications (2)

Publication Number Publication Date
EA201201666A1 true EA201201666A1 (ru) 2013-05-30
EA020271B1 EA020271B1 (ru) 2014-09-30

Family

ID=45097542

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201201666A EA020271B1 (ru) 2010-06-08 2011-06-08 Промежуточные соединения агомелатина и способ их получения

Country Status (40)

Country Link
US (1) US8779199B2 (ru)
EP (1) EP2580189B1 (ru)
JP (1) JP5519863B2 (ru)
KR (1) KR101470874B1 (ru)
CN (1) CN102276492B (ru)
AP (1) AP3205A (ru)
AU (1) AU2011264206B2 (ru)
BR (1) BR112012031086B1 (ru)
CA (1) CA2801822C (ru)
CL (1) CL2012003371A1 (ru)
CR (1) CR20120592A (ru)
CU (1) CU24148B1 (ru)
CY (1) CY1119857T1 (ru)
DK (1) DK2580189T3 (ru)
EA (1) EA020271B1 (ru)
EC (1) ECSP12012328A (ru)
ES (1) ES2656968T3 (ru)
GE (1) GEP20156234B (ru)
GT (1) GT201200328A (ru)
HR (1) HRP20171751T1 (ru)
HU (1) HUE035850T2 (ru)
IL (1) IL223180A (ru)
LT (1) LT2580189T (ru)
MA (1) MA34292B1 (ru)
ME (1) ME02992B (ru)
MX (1) MX2012013870A (ru)
MY (1) MY160954A (ru)
NI (1) NI201200177A (ru)
NO (1) NO2580189T3 (ru)
NZ (1) NZ604081A (ru)
PE (1) PE20130252A1 (ru)
PL (1) PL2580189T3 (ru)
PT (1) PT2580189T (ru)
RS (1) RS56659B1 (ru)
SG (1) SG185667A1 (ru)
SI (1) SI2580189T1 (ru)
TN (1) TN2012000542A1 (ru)
UA (1) UA104684C2 (ru)
WO (1) WO2011153939A1 (ru)
ZA (1) ZA201208764B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012046253A2 (en) * 2010-10-08 2012-04-12 Msn Laboratories Limited Process for the preparation of n-[2- (7-methoxy-l-naphthyl) ethyl] acetamide and its novel crystalline forms
CN102452951B (zh) * 2010-10-25 2014-02-19 天津泰普药品科技发展有限公司 阿戈美拉汀及其药物组合物
ITMI20121444A1 (it) 2012-08-27 2014-02-28 Procos Spa Processo per la produzione di agomelatine
EP2921473B1 (en) * 2012-10-09 2017-09-27 Jiangxi Synergy Pharmaceutical Co. Ltd. 1-cyan-1-(7-methoxyl-1-naphtyl) methanol ester compound and preparation method and use thereof
CN112574066A (zh) * 2019-09-27 2021-03-30 江苏豪森药业集团有限公司 一种阿戈美拉汀中间体的制备方法
JP2023506144A (ja) * 2019-12-23 2023-02-15 ディーエスエム アイピー アセッツ ビー.ブイ. 脱水素化方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE10229842A1 (de) 2002-07-03 2004-02-05 Helmut Prof. Dr. Schmidhammer Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung
FR2866334B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese du (7-methoxy-1-naphtyl) acetonitrile et application a la synthese de l'agomelatine
FR2866335B1 (fr) 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
FR2866336B1 (fr) * 2004-02-13 2006-03-24 Servier Lab Nouveau procede de synthese du (7-methoxy-3,4-dihydro-1-naphtalenyl) acetonitrile et application a la synthese de l'agomelatine
CN101472884A (zh) * 2006-06-20 2009-07-01 弗·哈夫曼-拉罗切有限公司 1,2,3,4-四氢化萘和茚满衍生物及其用途
CN101486665B (zh) * 2009-03-03 2013-04-17 上海医药工业研究院 阿戈美拉汀中间体2-(7-甲氧基-1-萘基)乙酰胺的制备方法
EP2705023A4 (en) * 2011-01-04 2014-11-19 Symed Labs Ltd PROCESSES FOR THE PREPARATION OF N- [2- (7-METHOXY-1-NAPHTHYLLELYHYL) ACETAMIDE

Also Published As

Publication number Publication date
WO2011153939A1 (en) 2011-12-15
MA34292B1 (fr) 2013-06-01
ME02992B (me) 2018-10-20
PT2580189T (pt) 2017-12-06
US20130267738A1 (en) 2013-10-10
DK2580189T3 (da) 2018-01-29
KR20130028134A (ko) 2013-03-18
NZ604081A (en) 2014-01-31
GT201200328A (es) 2014-06-09
AU2011264206A1 (en) 2012-12-13
US8779199B2 (en) 2014-07-15
IL223180A (en) 2014-06-30
CR20120592A (es) 2013-03-04
JP5519863B2 (ja) 2014-06-11
ECSP12012328A (es) 2012-12-28
LT2580189T (lt) 2017-12-11
EP2580189B1 (en) 2017-10-25
ZA201208764B (en) 2014-01-29
SI2580189T1 (en) 2018-01-31
NO2580189T3 (ru) 2018-03-24
IL223180A0 (en) 2013-02-03
AP3205A (en) 2015-03-31
CY1119857T1 (el) 2018-06-27
AP2013006659A0 (en) 2013-01-31
UA104684C2 (ru) 2014-02-25
EP2580189A1 (en) 2013-04-17
EA020271B1 (ru) 2014-09-30
TN2012000542A1 (en) 2014-04-01
HRP20171751T1 (hr) 2017-12-29
JP2013531639A (ja) 2013-08-08
SG185667A1 (en) 2012-12-28
MY160954A (en) 2017-03-31
RS56659B1 (sr) 2018-03-30
PL2580189T3 (pl) 2018-04-30
AU2011264206B2 (en) 2013-08-15
NI201200177A (es) 2013-02-06
BR112012031086B1 (pt) 2020-12-08
BR112012031086A2 (pt) 2017-06-20
CA2801822C (en) 2015-03-24
CU20120163A7 (es) 2013-01-30
KR101470874B1 (ko) 2014-12-09
CN102276492A (zh) 2011-12-14
CU24148B1 (es) 2016-02-29
CN102276492B (zh) 2013-04-10
PE20130252A1 (es) 2013-03-16
MX2012013870A (es) 2013-01-24
ES2656968T3 (es) 2018-03-01
GEP20156234B (en) 2015-01-26
CL2012003371A1 (es) 2013-03-22
CA2801822A1 (en) 2011-12-15
HUE035850T2 (en) 2018-05-28
EP2580189A4 (en) 2016-01-06

Similar Documents

Publication Publication Date Title
EA201201666A1 (ru) Промежуточные соединения агомелатина и способ их получения
PH12015501258A1 (en) Methods of synthesizing a prostacyclin analog
WO2014043706A8 (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
MX2013011257A (es) Proceso para la preparacion de dronedarona por n-butilacion.
DK2019114T3 (da) Fremgangsmåde til fremstilling af Drospirenon
MX2020010773A (es) Metodo para la preparacion del compuesto de pirroloaminopiridazino na y sus intermedios.
MX2015010934A (es) Metodo para producir un compuesto triciclico, y un compuesto triciclico capaz de producirse por dicho metodo de produccion.
EA201990237A1 (ru) Новые способы получения стимуляторов растворимой гуанилатциклазы
EA200801348A1 (ru) Способ получения промежуточных соединений хлорамфеникола или его аналогов
MX2018010128A (es) Toxina nueva y metodo de preparacion de un intermediario de la misma.
MX2023000059A (es) Metodo de preparacion de compuesto de fenilisoxazolina.
MY147894A (en) Process for preparing intermediate compound for synthesizing an antiulcerant
RU2550510C1 (ru) Способ получения этил(4е)-5-хлорпент-4-еноата
EA202090650A1 (ru) Способ прямого получения этанола из синтез-газа
JP5918624B2 (ja) 光学活性含フッ素5,6−ジヒドロピリドン誘導体及びその製造方法
CN105541797A (zh) 盐酸巴尼地平的合成工艺
CO6592020A2 (es) Intemedios de agomelatina y método de preparación de éstos
PH12021550022A1 (en) Spirobiindane derivatives and a process for preparation thereof
RU2515240C1 (ru) Способ получения 1-[(2е,4е)-дека-2,4-диеноил]пирролидина
CN103880705B (zh) 二肟基紫罗兰酮及其制备方法和应用
MD3889B1 (en) Process for obtaining 11-bishomodrim-8(9)-en-12-one
RU2500664C1 (ru) Способ получения (2е,4е)-n-изобутилдека-2,4-диенамида
JP5964727B2 (ja) α―フムラジエノンの製造方法
TH133952A (th) สารมัธยันตร์อะโกเมลาทีน (Agomelatine intermediate) และ วิธีการเตรียมของสารนั้น
CN106117206A (zh) 医药中间体4-三氟甲基鸟嘌呤的合成方法